FDA Inspection
Novo Nordisk A/S - 25a-BFDA Inspection 1223821 - Novo Nordisk A/S - 25a-B - November 07, 2023
Record Details
This FDA Inspection record concerns Novo Nordisk A/S - 25a-B, with an inspection on November 7, 2023, issued by the Office of Inspections and Investigations.
- Company
- Novo Nordisk A/S - 25a-B
- Inspection Date
- November 7, 2023
View Company Profile
ID · 1311c640-239f-42db-a99a-a4b693406f50
Inspection Facts
- Inspection number
- 1223821
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Novo Nordisk A/S - 25a-B
7| Date | Classification | Office | Project area |
|---|---|---|---|
| November 4, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 14, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 22, 2016 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 18, 2015 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
| October 10, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Novo Nordisk A/S - 25a-B
- FDA Inspection 1207487 - 2022-11-04
- FDA Inspection 1118196 - 2018-06-14
- FDA Inspection 957571 - 2016-01-22
- FDA Inspection 933969 - 2015-06-18
- FDA Inspection 909374 - 2014-10-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.